ANI Pharmaceuticals Inc (ANIP) — Cash Flow Reinvestment Rate
ANI Pharmaceuticals Inc (ANIP) has a Cash Flow Reinvestment Rate of 0.79x as of December 2025, reinvesting $23.86 Million (capex $23.86 Million ) from operating cash flow of $30.37 Million. See ANIP free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ANI Pharmaceuticals Inc Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for ANI Pharmaceuticals Inc across 12 annual periods. For the full cash flow conversion analysis, see ANIP cash flow metrics.
Annual Cash Flow Reinvestment Rate for ANI Pharmaceuticals Inc (2007–2025)
Year-by-year capital reinvestment analysis for ANI Pharmaceuticals Inc. See ANI Pharmaceuticals Inc (ANIP) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | $13.84 Million | $185.22 Million | $13.84 Million | ▼ -98.9% |
| 2024 | 6.59x | $421.67 Million | $64.02 Million | $16.95 Million | ▲ +2114.4% |
| 2023 | 0.30x | $35.38 Million | $118.96 Million | $18.51 Million | ▼ -99.2% |
| 2021 | 38.87x | $129.12 Million | $3.32 Million | $23.64 Million | ▲ +334.3% |
| 2020 | 8.95x | $136.64 Million | $15.27 Million | $68.32 Million | ▲ +641.2% |
| 2019 | 1.21x | $55.10 Million | $45.63 Million | $27.55 Million | ▲ +111.5% |
| 2018 | 0.57x | $38.29 Million | $67.07 Million | $10.91 Million | ▼ -89.6% |
| 2017 | 5.48x | $215.99 Million | $39.42 Million | $107.99 Million | ▼ -50.3% |
| 2016 | 11.03x | $303.12 Million | $27.47 Million | $149.06 Million | ▲ +482.8% |
| 2015 | 1.89x | $32.68 Million | $17.26 Million | $32.68 Million | ▲ +16.7% |
| 2014 | 1.62x | $35.75 Million | $22.03 Million | $35.75 Million | ▲ +3980.5% |
| 2007 | 0.04x | $29.43K | $739.99K | $29.43K | — |